Allstate (ALL) CEO sells 16,807 shares under Rule 10b5-1

Allstate (ALL) CEO Thomas J. Wilson reported open-market sales totaling 16,807 shares on 10/20/2025 pursuant to a Rule 10b5-1 trading plan adopted on June 27, 2025.

Rhea-AI Filing Summary

Allstate (ALL) CEO Thomas J. Wilson reported open-market sales totaling 16,807 shares on 10/20/2025 pursuant to a Rule 10b5-1 trading plan adopted on June 27, 2025. Tranches executed at weighted-average prices of $193.6903, $194.3583, $195.5023, and $196.5001.

After the transactions, he directly owns 195,233.491 Allstate shares. He also reports indirect beneficial holdings, including 111,442 shares by the 2023-B GRAT and 273,954 shares by the 2020 GRAT Remainder Trust.

Insider Trade Summary

Net Seller: 16,807 shares

Net Sell 10 txns

Insider WILSON THOMAS J

Role Chairman, President & CEO

Sold 16,807 shs ($3.26M)

Type	Security	Shares	Price	Value
Sale	Common Stock	11,032	$193.6903	$2.14M
Sale	Common Stock	4,488	$194.3583	$872K
Sale	Common Stock	1,086	$195.5023	$212K
Sale	Common Stock	201	$196.5001	$39K
holding	Common Stock	--	--	--
holding	Common Stock	--	--	--
holding	Common Stock	--	--	--
holding	Common Stock	--	--	--
holding	Common Stock	--	--	--
holding	Common Stock	--	--	--

Holdings After Transaction: Common Stock — 195,233.491 shares (Direct); Common Stock — 111,442 shares (Indirect, By 2023-B GRAT); Common Stock — 65,321 shares (Indirect, By 2024-C GRAT); Common Stock — 69,822 shares (Indirect, By 2025-A GRAT); Common Stock — 7,647 shares (Indirect, By 401(k) Plan); Common Stock — 273,954 shares (Indirect, By 2020 GRAT Remainder Trust); Common Stock — 257,535 shares (Indirect, Remainder GRAT)

Footnotes (5)

1. F1. Reflects weighted average sale price for open-market sales transaction reported herein. Actual sale prices ranged from $193.010 to $194.00. The reporting person provided the issuer, and will provide any security holder of The Allstate Corporation or member of the SEC staff, full information regarding the number of shares sold at each separate price upon request.
2. F2. The sale transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted on June 27, 2025.
3. F3. Reflects weighted average sale price for open-market sales transactions reported herein. Actual sales prices ranged from $194.010 to $194.970. The reporting person provided to the issuer, and will provide to any security holder of The Allstate Corporation or member of the SEC staff, full information regarding the number of shares sold at each separate price upon request.
4. F4. Reflects weighted average sale price for open-market sales transaction reported herein. Actual sale prices ranged from $195.110 to $196.060. The reporting person provided the issuer, and will provide any security holder of The Allstate Corporation or member of the SEC staff, full information regarding the number of shares sold at each separate price upon request.
5. F5. Reflects weighted average sale price for open-market sales transaction reported herein. Actual sale prices ranged from $196.390 to $196.570. The reporting person provided the issuer, and will provide any security holder of The Allstate Corporation or member of the SEC staff, full information regarding the number of shares sold at each separate price upon request.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Allstate (ALL) disclose in this Form 4?

CEO Thomas J. Wilson reported open-market sales totaling 16,807 shares on 10/20/2025 in multiple tranches.

Were the ALL insider sales under a Rule 10b5-1 plan?

Yes. The sales were effected under a Rule 10b5-1 trading plan adopted on June 27, 2025.

What prices were the Allstate shares sold at?

Weighted-average prices were $193.6903, $194.3583, $195.5023, and $196.5001, each reflecting multiple trades.

How many Allstate shares does the CEO now hold directly?

Following the sales, Thomas J. Wilson directly owns 195,233.491 shares.

What indirect holdings were reported by the Allstate CEO?

Indirect positions include 111,442 shares by the 2023-B GRAT and 273,954 shares by the 2020 GRAT Remainder Trust, among others.

Who filed the report and when was it signed?

The report was signed by Thomas J. Wilson on 10/21/2025.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 10/22/2025 - 04:24 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

WILSON THOMAS J

(Last) (First) (Middle)

C/O THE ALLSTATE CORPORATION

3100 SANDERS ROAD

(Street)

NORTHBROOK IL 60062-7154

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
ALLSTATE CORP [ ALL ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chairman, President & CEO

3. Date of Earliest Transaction (Month/Day/Year)
10/20/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	10/20/2025		S		11,032	D	$193.6903(1)	201,008.491(2)	D
Common Stock	10/20/2025		S		4,488	D	$194.3583(3)	196,520.491(2)	D
Common Stock	10/20/2025		S		1,086	D	$195.5023(4)	195,434.491(2)	D
Common Stock	10/20/2025		S		201	D	$196.5001(5)	195,233.491(2)	D
Common Stock								111,442	I	By 2023-B GRAT
Common Stock								65,321	I	By 2024-C GRAT
Common Stock								69,822	I	By 2025-A GRAT
Common Stock								7,647	I	By 401(k) Plan
Common Stock								273,954	I	By 2020 GRAT Remainder Trust
Common Stock								257,535	I	Remainder GRAT

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Reflects weighted average sale price for open-market sales transaction reported herein. Actual sale prices ranged from $193.010 to $194.00. The reporting person provided the issuer, and will provide any security holder of The Allstate Corporation or member of the SEC staff, full information regarding the number of shares sold at each separate price upon request.

2. The sale transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted on June 27, 2025.

3. Reflects weighted average sale price for open-market sales transactions reported herein. Actual sales prices ranged from $194.010 to $194.970. The reporting person provided to the issuer, and will provide to any security holder of The Allstate Corporation or member of the SEC staff, full information regarding the number of shares sold at each separate price upon request.

4. Reflects weighted average sale price for open-market sales transaction reported herein. Actual sale prices ranged from $195.110 to $196.060. The reporting person provided the issuer, and will provide any security holder of The Allstate Corporation or member of the SEC staff, full information regarding the number of shares sold at each separate price upon request.

5. Reflects weighted average sale price for open-market sales transaction reported herein. Actual sale prices ranged from $196.390 to $196.570. The reporting person provided the issuer, and will provide any security holder of The Allstate Corporation or member of the SEC staff, full information regarding the number of shares sold at each separate price upon request.

	/s/ Thomas J. Wilson	10/21/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.